These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Improvement of diabetes insipidus after allogeneic bone marrow transplantation in a patient with myelodysplastic syndrome]. Sato N, Takayama N, Kizaki M, Ikeda Y, Okamoto S. Rinsho Ketsueki; 2003 May; 44(5):318-22. PubMed ID: 12822406 [Abstract] [Full Text] [Related]
7. [Acute myelomonocytic leukemia with mastocytosis in bone marrow]. Natori H, Nakamura E, Tanaka K, Naito K, Egami K, Honda J, Osabe S, Imamura Y, Natori K, Yasuda K. Rinsho Ketsueki; 1990 Feb; 31(2):239-44. PubMed ID: 2329687 [Abstract] [Full Text] [Related]
8. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome. Schlesinger M, Silverman LR, Jiang JD, Yagi MJ, Holland JF, Bekesi JG. J Clin Lab Immunol; 1996 Feb; 48(4):149-66. PubMed ID: 9819667 [Abstract] [Full Text] [Related]
13. Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes. Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG). De Witte T, Zwaan F, Hermans J, Vernant J, Kolb H, Vossen J, Lönnqvist B, Beelen D, Ferrant A, Gmür J. Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():38-9. PubMed ID: 2697398 [Abstract] [Full Text] [Related]